# HPV Vaccine, Imiquimod, and Metformin Combination Trial

> **NCT06686043** · PHASE2 · RECRUITING · sponsor: **Baylor College of Medicine** · enrollment: 85 (estimated)

## Conditions studied

- Cervical Carcinoma
- Vaginal Carcinoma
- Vulvar Carcinoma
- HPV (Human Papillomavirus)-Associated Carcinoma

## Interventions

- **DRUG:** HPV vaccine, Imiquimod, and metformin combination therapy

## Key facts

- **NCT ID:** NCT06686043
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-23
- **Primary completion:** 2026-08-23
- **Final completion:** 2028-08-23
- **Target enrollment:** 85 (ESTIMATED)
- **Last updated:** 2024-11-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06686043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06686043, "HPV Vaccine, Imiquimod, and Metformin Combination Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06686043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*